• Angiotensin 1/2 (2-7): Mechanistic Insights for Advanced RAS

  2026-04-21

  Explore the scientific mechanisms and assay utility of Angiotensin 1/2 (2-7), a vasoconstrictor peptide critical for blood pressure regulation research. Unique to this article: a deep dive into recent breakthroughs linking peptide structure to SARS-CoV-2 spike protein interactions and their implications for experimental design.

• CD163+ Macrophage Activation Drives Granulosa Cell Apoptosis

  2026-04-20

  This study identifies CD163+ macrophage activation as a key driver of granulosa cell apoptosis in polycystic ovary syndrome (PCOS), establishing an inflammatory mechanism central to ovarian dysfunction. The research leverages a DHEA-induced mouse model and patient serum analysis, offering mechanistic insight with translational implications for targeted intervention.

• Dissecting SPEN–XIST Interactions: Sequence and Structure In

  2026-04-20

  This study reveals the structural and sequence determinants required for high-affinity binding between the SPEN protein and the XIST A-repeat RNA, a critical step in X chromosome inactivation. Insights from in vitro assays elucidate how specific RNA motifs and SPEN domains drive this interaction, informing future RNA–protein studies and probe design.

• Doxorubicin Hydrochloride: Optimizing Cancer and Cardiotoxic

  2026-04-19

  Doxorubicin hydrochloride (Adriamycin HCl) is the gold standard for modeling both cytotoxicity and cardiotoxicity in translational oncology research. This article delivers actionable protocols, troubleshooting insights, and highlights a novel ATF4/H2S cardioprotective axis to help researchers drive reproducible, mechanistically rigorous studies.

• Nuclear cGAS Limits L1 Retrotransposition via TRIM41-Mediate

  2026-04-18

  This study establishes that nuclear cGAS restricts LINE-1 (L1) retrotransposition in human cells by promoting the TRIM41-mediated ubiquitination and degradation of the L1-encoded ORF2p protein. The findings reveal a previously unappreciated genome-preserving role for nuclear cGAS, with implications for understanding DNA damage response, aging, and tumorigenesis.

• PreScission Protease: Precision HRV 3C Cleavage in Protein P

  2026-04-17

  PreScission Protease (PSP) delivers high-specificity HRV 3C cleavage for seamless removal of fusion protein tags, enabling recovery of native proteins under low-temperature conditions. Its robust performance streamlines workflows in advanced molecular biology and condensate research, setting a new standard for reproducibility and fidelity.

• Viral Evasion of Iron Withholding via FPN1: Mechanistic Insi

  2026-04-16

  This study uncovers how viral infections manipulate host iron homeostasis by promoting FPN1 degradation, elevating cellular iron, and thereby suppressing type I interferon and autophagy-based defenses. The findings highlight a previously underappreciated mechanism of immune evasion with broad implications for antiviral research and experimental design.

• Verapamil HCl in Translational Research: Calcium Channel Blo

  2026-04-15

  Verapamil HCl empowers researchers to interrogate L-type calcium channel function, dissect apoptosis in myeloma, and unravel bone turnover mechanisms in osteoporosis. This guide translates recent bench breakthroughs—including TXNIP-targeting workflows—into actionable protocols, troubleshooting insights, and comparative advantages for innovative disease modeling.

• Phenothiazines Induce Macrophage Autophagy and ROS for Antib

  2026-04-14

  This study demonstrates that phenothiazines, including dopamine D2 receptor inhibitors, enhance the antibacterial activity of macrophages by promoting autophagy and ROS production. The findings identify a host-directed therapeutic approach with implications for tackling intracellular bacterial infections and antibiotic resistance.

• Optimizing hiPSC-Derived Platelet Production with Small Mole

  2026-04-13

  This study presents a systematic protocol optimization that increases the efficiency and reduces the cost of generating functional platelets from human induced pluripotent stem cells (hiPSCs). By integrating higher embryoid body cell inputs, serum-free media with human platelet lysate, and strategic small molecule supplementation—including kinase inhibitors—the authors report a significant improvement in both megakaryocyte and platelet yields, with potential broad impact for cell therapy and research applications.

• Strategic Rho/ROCK Pathway Inhibition with Fasudil (HA-1077)

  2026-04-13

  This thought-leadership article explores the mechanistic and translational value of Fasudil (HA-1077) HCl, a selective ROCK inhibitor, in modulating cell proliferation, migration, and apoptosis across cancer and hematologic models. Drawing parallels and distinctions with emerging Hippo pathway research—including recent findings on quercetin’s protective effects in cataractogenesis—the article contextualizes APExBIO’s Fasudil as a pivotal reagent for next-generation disease modeling and therapy innovation. It delivers actionable protocol guidance, competitive analysis, and a forward-looking perspective on pathway crosstalk, uniquely equipping translational researchers to accelerate discovery beyond conventional boundaries.

• Scenario-Driven Use of Ibrutinib (PCI-32765) BTK Inhibitor (

  2026-04-12

  This article addresses common laboratory challenges in cell viability and signaling assays by providing evidence-based guidance for using Ibrutinib (PCI-32765) Bruton's Tyrosine Kinase (BTK) Inhibitor (SKU A3001). Drawing on published data and real-world scenarios, it outlines best practices for experimental design, protocol optimization, and vendor selection—empowering scientists to achieve reproducible, high-impact results in B-cell and ATRX-deficient glioma research.

• Monomethyl auristatin E: Precision Payloads for Advanced Can

  2026-04-12

  Monomethyl auristatin E (MMAE) is redefining targeted cancer therapy by enabling high-potency antibody-drug conjugates with minimal off-target toxicity. This guide covers experimental workflows, protocol optimization, and troubleshooting strategies to unlock MMAE’s translational impact in solid tumor models and beyond.

• Cyclophosphamide: Applied Workflows for Cancer Research Exce

  2026-04-11

  Cyclophosphamide from APExBIO sets the benchmark for apoptosis induction and immune modulation in cancer and transplantation studies. This article translates advanced protocols and troubleshooting insights into actionable steps for robust experimental outcomes.

• Dabigatran: Applied Thrombin Inhibition for Coagulation Assa

  2026-04-11

  Dabigatran (Pradaxa) delivers reproducible, high-sensitivity thrombin inhibition for advanced coagulation research, supporting both standard and translational workflows. Explore protocol parameters, real-world troubleshooting, and comparative data to optimize your thrombin inhibition assays with confidence.

11222 records 1/749 page Next 12345 下5页 Last page